SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Computer Motion (RBOT)
RBOT 2.650-7.3%Jan 16 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: ZUYDERZ who wrote (715)4/22/1999 7:06:00 PM
From: James Hutton  Read Replies (1) of 793
 
CC was pretty positive. I think the thinking was that Zeus would be approved this year. That may disappoint some. Stryker issue could be positive or negative. I think Stryker has exclusive agreement on Hermes. This limits the platforms (to Stryker's) upon which Hermes can be used. It would seem that if RBOT can get out of Exclusive with Stryker, then it could broaden the platforms upon which Hermes could be used. Aesop doesn't seem to be that big of a deal since it is now being packaged with Zeus.

My guess is a lower open tomorrow, with weakness continuing. Long-term story intact.

Good luck.

Jon
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext